Stout's client, Terumo Cardiovascular Systems Group, sold its Cannulae Product Lines business to MC3, Inc. Stout served as exclusive financial advisor to Terumo CVG in connection with this transaction.

Terumo CVG, headquartered in Ann Arbor, MI, is a leading manufacturer, marketer, and distributor of medical devices for the global cardiac and vascular surgery markets. Terumo CVG’s Cannulae business includes nearly 200 cannulae designed to suit a variety of cardiac and vascular procedures, including arterial cannulae, venous cannulae, cardioplegia cannulae, and other related products. Terumo CVG’s parent company, Terumo Corp., is a global medical device manufacturer focused on cardiac and vascular specialties, hospital products, and home healthcare with more than 11,000 associates in 82 sales offices and 17 production facilities around the world.